Review Articles

ABOUT AUTHOR:
Rajesh G. Dobariya
shree M.&N. Virani Science College,
Rajkot
drajesh47@gmail.com

ABSTRACT
Single cell protein typically refers to source of mixed protein extracted from pure or mixed culture of algae, yeast, fungi or bacteria. The microbes which are used for single cell protein production must be non-pathogenic to plants, animals and man. Good nutritional value, easily and cheaply produced on scale, toxin free, fast growing, easily to separate from the medium and to dry. They have many silent feature. Biomass production is ordinarily carried out in continuous mode to maximize yields and economic scale. The raw material of this process is very cheap because we used molasses, whey, gas, oil etc. For a substrate. So SCP is waste to best. The molasses and various salts including ammonium and phosphate salt contain of the baker’s yeast. The yeast are used for the production of SCP. The baker’s yeast is useful to as and they create disadvantages also the SCP and baker’s yeast very useful for organism.

ABOUT AUTHOR:
Muhammad Mujahed
M.Sc Biotechnology
Swami Ramanand Teerth Marathwada University, Vishnupuri , Nanded.
mujubiotech2011@rediffmail.com

INTRODUCTION:
A few decades ago, it was realized that certain proteins could be used as pharmaceutical agents for the treatment of human diseases. e.g. insulin for diabetes mellitus, interferon for viral diseases. However the availability of such therapeutic/ pharmaceutical products was limited due to costly and cumbersome procedures involved in their isolation. Further, their use in humans was associated with several complications. For instance, administration of pig insulin to diabetic patients results in the development of antibodies.

The advent of recombinant DNA technology heralded a new chapter for the production of a wide range of therapeutic agents in sufficient quantities for human use. The commercial exploitation of recombinant DNA  (rDNA) technology began in late 1970s by biotechnological companies to produce proteins.There are around 400 different proteins being produced  by rDNAtechnologyand as of now around 30 have been approved for human use.

ABOUT AUTHORS:
Ashutosh Kumar Dubey*^[1], Vishal Jackob^[1], Srishti Srivastava^[1], Anusha Srivastaav^[2]
1Institute of Foreign Trade and Management
²Rajiv Academy of Pharmacy
*srishtiiftm@gmail.com

About author:
Priya Diwedi
M.Pharm
Bhopal institute of technology and science-pharmacy, Bhopal (M.P)
Priya.diwedi07@gmail.com

About Author:
Akshay Rajgaria
Kanak Manjari Institute of Pharmaceutical Sciences
akshaykrish2007@gmail.com

ABSTRACT
Transdermal drug delivery system (TDDS) provides a means to sustain drug release as well as reduce the intensity of action and thus reduce the side effects associated with its oral therapy. Transdermal drugs are self contained, discrete dosage form. Transdermal Drug Delivery System is the system in which the delivery of the active ingredients of the drug occurs by the means of skin. Skin is an effective medium from which absorption of the drug takes place and enters the circulatory system. Various types of transdermal patches are used to incorporate the active ingredients into the circulatory system via skin. The patches have been proved effective because of its large advantages over other controlled drug delivery systems.

About Authros:
Khushbu Singh*¹, Chandana Majee^2
1 M.Pharm ( department of pharmaceutics)
² Assistant Professor, department of pharmaceutical chemistry.
Noida institute of engineering and technology, noida
*khushbu1991singh@gmail.com